BlackRock Inc. Buys 292,563 Shares of Steris PLC (STE)
BlackRock Inc. raised its holdings in shares of Steris PLC (NYSE:STE) by 4.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,476,972 shares of the medical equipment provider’s stock after acquiring an additional 292,563 shares during the period. BlackRock Inc. owned approximately 0.09% of Steris worth $698,051,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Lazard Asset Management LLC raised its stake in Steris by 11.5% during the 4th quarter. Lazard Asset Management LLC now owns 139,722 shares of the medical equipment provider’s stock valued at $12,221,000 after acquiring an additional 14,425 shares in the last quarter. Dupont Capital Management Corp bought a new stake in Steris during the 4th quarter valued at $2,318,000. Arizona State Retirement System raised its stake in Steris by 27.1% during the 4th quarter. Arizona State Retirement System now owns 61,218 shares of the medical equipment provider’s stock valued at $5,355,000 after acquiring an additional 13,057 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Steris by 45.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,752 shares of the medical equipment provider’s stock valued at $416,000 after acquiring an additional 1,476 shares in the last quarter. Finally, Suntrust Banks Inc. raised its stake in Steris by 42.2% during the 4th quarter. Suntrust Banks Inc. now owns 48,685 shares of the medical equipment provider’s stock valued at $4,257,000 after acquiring an additional 14,447 shares in the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.
In other news, Director Richard Martin Steeves sold 58,953 shares of Steris stock in a transaction on Monday, March 5th. The stock was sold at an average price of $91.00, for a total transaction of $5,364,723.00. Following the transaction, the director now directly owns 9,362 shares in the company, valued at approximately $851,942. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Karen L. Burton sold 1,204 shares of Steris stock in a transaction on Friday, May 11th. The shares were sold at an average price of $102.74, for a total value of $123,698.96. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 109,362 shares of company stock worth $10,445,737. 2.55% of the stock is owned by insiders.
Shares of Steris opened at $103.84 on Friday, MarketBeat Ratings reports. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.97 and a current ratio of 2.48. The firm has a market cap of $8.82 billion, a price-to-earnings ratio of 25.02 and a beta of 1.12. Steris PLC has a 1-year low of $76.47 and a 1-year high of $105.47.
Steris (NYSE:STE) last issued its quarterly earnings results on Wednesday, May 9th. The medical equipment provider reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.02. Steris had a return on equity of 11.55% and a net margin of 11.10%. The company had revenue of $716.00 million for the quarter, compared to analysts’ expectations of $703.37 million. During the same period last year, the firm earned $1.11 EPS. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. research analysts forecast that Steris PLC will post 4.71 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, June 28th. Stockholders of record on Friday, June 8th will be given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.19%. The ex-dividend date is Thursday, June 7th. Steris’s dividend payout ratio (DPR) is presently 29.88%.
STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.